Zobrazeno 1 - 10
of 180
pro vyhledávání: '"Abhijit, Pal"'
Autor:
Ashfaq Chauhan, Upma Chitkara, Ramya Walsan, Ursula M. Sansom-Daly, Elizabeth Manias, Davinia Seah, Angie Dalli, Nadine El-Kabbout, Thit Tieu, Mashreka Sarwar, Misbah Faiz, Nancy Huang, Vitor Moraes Rocha, Abhijit Pal, Reema Harrison
Publikováno v:
BMC Palliative Care, Vol 23, Iss 1, Pp 1-11 (2024)
Abstract Background Advance care planning (ACP) describes the process of supporting individuals at any age or stage of health to consider and share their personal values, life goals, and preferences regarding future health care. Engaging in ACP is as
Externí odkaz:
https://doaj.org/article/6cb44ee3d1a3452189bd2ec9ed00528a
Autor:
Udit Nindra, Adel Shahnam, Samuel Stevens, Abhijit Pal, Adnan Nagrial, Jenny Lee, Po Yee Yip, Tamiem Adam, Michael Boyer, Steven Kao, Victoria Bray
Publikováno v:
Thoracic Cancer, Vol 13, Iss 21, Pp 3058-3062 (2022)
Abstract Sustained elevation in neutrophil‐to‐lymphocyte ratio (NLR) after initial chemoradiotherapy (CRT) has been shown to correlate with worse prognosis in a number of solid organ malignancies. Here, we conducted a retrospective observational
Externí odkaz:
https://doaj.org/article/7a4cd723958e4e11906e35ac25e41b11
Autor:
Crescens Tiu, Rajiv Shinde, Abhijit Pal, Andrea Biondo, Alex Lee, Nina Tunariu, Shaman Jhanji, Vimal Grover, Kate Tatham, Pascale Gruber, Udai Banerji, Johann S. De Bono, Emma Nicholson, Anna R. Minchom, Juanita S. Lopez
Publikováno v:
Journal of Immunotherapy and Precision Oncology, Pp 189-195 (2021)
Introduction: Immune checkpoint inhibitors (ICIs) are increasingly a standard of care for many cancers; these agents can result in immune-related adverse events (irAEs) including fever, which is common but can rarely be associated with systemic immun
Externí odkaz:
https://doaj.org/article/795643acaadb42b992e7de8af283b261
Autor:
Udit Nindra, Abhijit Pal, Vivienne Lea, Stephanie Hui-Su Lim, Kate Wilkinson, Ray Asghari, Tara L Roberts, Therese M Becker, Mahtab Farzin, Tristan Rutland, Mark Lee, Scott MacKenzie, Weng Ng, Bin Wang, C Soon Lee, Wei Chua
Publikováno v:
PLoS ONE, Vol 18, Iss 10, p e0292087 (2023)
BackgroundNext generation sequencing (NGS) is increasingly used in standard clinical practice to identify patients with potentially actionable mutations. Stratification of NGS mutation tiers is currently based on the European Society of Medical Oncol
Externí odkaz:
https://doaj.org/article/96a4f02f3945468bab367622f96e9e7b
Autor:
Robert Brown, Christina Yap, Johann De Bono, Malaka Ameratunga, Anna Minchom, Wei Yuan, Mateus Crespo, Bora Gurel, Ines Figueiredo, Susana Miranda, Ruth Riisnaes, Ana Ferreira, Claudia Bertan, Rita Pereira, Chloe Baker, Nina Tunariu, Suzanne Carreira, Udai Banerji, Juanita Lopez, Alison Turner, Wentin Chen, Abhijit Pal, Dionysis Papadatos-Pastos, Toby Prout, Maxime Chénard-Poirier, Andra Curcean, Nahal Masrour, Ricardo Morilla, Ben Jenkins, Anna Zachariou, Mona Parmar
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 6 (2022)
Externí odkaz:
https://doaj.org/article/b9a84246b2264ed1b2c2acbbf2f19d79
Autor:
Christina Yap, Deme Karikios, Johann De Bono, Anna Minchom, Udai Banerji, Juanita Lopez, Sarah Stapleton, Frances Boyle, Abhijit Pal, Julia Lai-Kwon, Robert Daly, Dimitrios Magkos, Bindumalini Rao Baikady
Publikováno v:
BMJ Open, Vol 11, Iss 9 (2021)
Introduction Early phase cancer clinical trials have become increasingly complicated in terms of patient selection and trial procedures—this is reflected in the increasing length of participant information sheets (PIS). Informed consent for early p
Externí odkaz:
https://doaj.org/article/b5e4da0c65834b85bca76b00cf5340d0
Autor:
Tirthankar Bhandary, Hirak Satpathi, Aratrika Banerjee, Koushik Pal, Abhijit Pal, Barun Kumar Samui, Saikat Dasgupta, Rabindra Mukhopadhyay
Publikováno v:
Organic Polymer Material Research. 5:1-11
Blends of synthetic rubbers are widely used by rubber product manufacturing industries depending on the end use and product application. The estimation of individual rubber in blends is an important aspect to characterise the correctness of the mixin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3c46df01e8469b30bb1219d4e79da07b
https://doi.org/10.30564/opmr.v5i1.5368
https://doi.org/10.30564/opmr.v5i1.5368
Publikováno v:
Clinical Genitourinary Cancer. 21:183-193
There is emerging evidence for the use of poly (ADP-ribose) polymerase inhibitors (PARPi) in patients with mCRPC with patients harboring germline or somatic mutations deriving clinical benefit. However, the toxicity profile of PARPi in mCRPC is not w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc7e1dbaea4f66580c35581e72e8ff8c
https://doi.org/10.1016/j.clgc.2022.07.005
https://doi.org/10.1016/j.clgc.2022.07.005
Autor:
Andrea Biondo, Abhijit Pal, Ruth Riisnaes, Rajiv Shinde, Crescens Tiu, Fran Lockie, Chloe Baker, Claudia Bertan, Mateus Crespo, Ana Ferreira, Rita Pereira, Ines Figueiredo, Susana Miranda, Bora Gurel, Suzanne Carreira, Udai Banerji, Johann de Bono, Juanita Lopez, Nina Tunariu, Anna Minchom
Publikováno v:
Cancer Treatment and Research Communications, Vol 27, Iss , Pp 100309- (2021)
ABSTRACT: Early-phase cancer clinical trials are becoming increasingly accessible for patients with advanced cancer who have exhausted standard treatment options and later phase trial options. Many of these trials mandate research tissue biopsies. Re
Externí odkaz:
https://doaj.org/article/7ee213af1fdd4bdb8f1be7e81291035f
Autor:
Tamkin Ahmadzada, BE, Wendy A. Cooper, BScMed, M.B.B.S., PhD, FRCPA, Mikaela Holmes, BBiomedSc, Annabelle Mahar, M.B.B.S., FRCPA, Helen Westman, MPH, Anthony J. Gill, MD, FRCPA, Ina Nordman, M.B.B.S., FRACP, M(Med)Sc, Po Yee Yip, MbChB., FRACP, PhD, Abhijit Pal, BSc (Hons), M.B.B.S., FRACP, Rob Zielinski, FRACP, M.B.B.S., Hons, Nick Pavlakis, BSc, M.B.B.S., MMed (Clin Epi), PhD, FRACP, Adnan Nagrial, M.B.B.S., PhD, Dariush Daneshvar, MD, FRCPA, Daniel Brungs, M.B.B.S., MMed (Clin Epi), FRCPA, Deme Karikios, BSc, M.B.B.S., FRACP, PhD, Vesna Aleksova, BMedSc, Juliet Burn, M.B.B.S., FRCPA, MIAC, Rebecca Asher, MSc, Georges E. Grau, MD, PhD, Elham Hosseini-Beheshti, MSc, PhD, Glen Reid, PhD, Stephen Clarke, MD, PhD, FRACP, Steven Kao, BHB, MbChB., PhD, FRACP
Publikováno v:
JTO Clinical and Research Reports, Vol 1, Iss 4, Pp 100075- (2020)
Introduction: We investigated the efficacy and toxicity of pembrolizumab in patients with mesothelioma from a real-world Australian population. We aimed to determine clinical factors and predictive biomarkers that could help select patients who are l
Externí odkaz:
https://doaj.org/article/8decaaa69f954183bf0aaa4a972c4d8b